ARCHIVES

Higgins: VA Groups D Have Review; NCI: It’s Ad Hoc

This article is from The Cancer Letter archive.

Vol. 03 No. 48 | December 2, 1977

Download PDF Visit The Full Archive

Related Articles

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

January 30, 2009

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

NCI Director’s Office Gets Makeover In Reorganization Plan.

December 8, 2006

Moses To Lead AACI.

October 19, 2001